Navigation Links
Genoptix Announces Participation at the RBC Capital Markets 2008 Healthcare Conference
Date:12/2/2008

CARLSBAD, Calif., Dec. 2 /PRNewswire-FirstCall/ -- Genoptix, Inc. (Nasdaq: GXDX), a specialized laboratory services provider, today announced the Company's participation at the RBC Capital Markets 2008 Healthcare Conference scheduled to take place at the Westin New York Hotel at Times Square on December 10-11, 2008.

Sam Riccitelli, COO and executive vice president of Genoptix, will take part in a panel discussion at the conference on Wednesday, December 10, beginning at approximately 12:30 p.m. EST. Mr. Riccitelli will provide an overview of the Company's specialized diagnostic laboratory service offerings, growth strategies and past operational performance.

The panel discussion on personalized medicine is expected to last approximately 55 minutes, including an audience Q&A session, and will be web cast live and made accessible through the investor relations section of the Genoptix website at www.genoptix.com. Those who would like to listen to the presentation should go to this site at least 15 minutes prior to the event to register, download and install any necessary software. A replay will also be available for 30 days following the initial presentation web cast.

About Genoptix, Inc.

Genoptix is a leading specialized laboratory service provider focused on delivering personalized and comprehensive diagnostic services to its physician customers, community-based hematologists and oncologists. On the forefront of personalized diagnostic services, Genoptix's highly trained group of hematopathologists utilize sophisticated technology to provide integrated testing and actionable diagnostic reports. Its diagnostic services are designed to optimize the care of patients suffering from hematomalignancies, or cancers of the blood and bone
'/>"/>

SOURCE Genoptix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Genoptix Reports Strong Financial Results for the Third Quarter and Raises Guidance for Full-Year 2008
2. Genoptix Announces the Addition of New Members to Board of Directors
3. Genoptix Reports Strong Financial Results for the Second Quarter and Raises Guidance for Full-Year 2008
4. Genoptix Reports Strong Financial Results for First Quarter 2008
5. Genoptix Announces Participation at the Bank of America 2008 Healthcare Conference
6. Genoptix Announces 2008 Annual Stockholders Meeting and Date of Record
7. Genoptix Announces Participation at Lehman Brothers 11th Annual Global Health Care Conference
8. Genoptix Announces Participation at Cowen and Company 28th Annual Health Care Conference
9. Genoptix Announces Pricing of Secondary Public Offering
10. Genoptix Announces Filing of Registration Statement for Secondary Public Offering of Common Stock
11. Genoptix Reports Strong Financial Results for the Fourth Quarter and Full Year 2007

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...s announced that it has become a national sponsor ...nprofit organizations dedicated to arthritis resea... Delray Beach, FL (Vocus) November 27, 20...pany specializing in the marketing and retail dist...unced today that is has become a national sponsor ...
(Date:11/27/2009)...economic burdens, study predicts , , FRI...ple with diabetes in the United States is expected...dicts. , That would bring the total by 2034 to ...m 23.7 million today. , , At the same time, the ... the study also warns, rising from an estimated $1...
(Date:11/27/2009)... announced today that Spectrum Health (Grand Rapid... orthopedic templating solution and its TraumaCad ... (PRWEB) November 27, 2009 -- Voyant Health&trad...ids, Michigan) has licensed its TraumaCad Enterpri...d Extend workflow solution, to allow its orthopedi...
(Date:11/27/2009)...rers who use medical load cells at the heart of th...nging in technology partner Flintec early in the d...dical manufacturers are calling in Flintec load ce... ensuring that progress will not be constrained by... technology. , (PRWEB) No...
(Date:11/26/2009)...With cold and flu season upon us, it,s more import...the spread of infections and avoid illness. ,, ...s healthy, but to avoid transmitting illness if we...fied in infection-control), nursing director for i...al for Special Surgery (HSS) in Manhattan. ,, H...
Breaking Medicine News(10 mins):Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4
...ican College of Allergy,Asthma & Immunology (ACAAI...merica surveys that highlight the importance of im...These survey findings and other important,informat...driving the dialogue about unmet needs for patient...
... 22 Medco Health,Solutions, Inc., (NYSE: MHS ) t...dHealth Group to provide pharmacy benefit services...ext generation of collaboration with,UnitedHealth ...p and includes new terms that provide clear alignm...
... To enhance absorption, the,Longevinex(R) matrix ...resveratrol, microencapsulated in an envelope of a... resveratrol in its trans-resveratrol form,from de...resveratrol matrix withstands direct,exposure to s...
...ERTIFICATION PROGRAM CONTINUES TO EXPAND IN THE ... April 22 More people than ever,before are buying...,standards -- especially people with asthma and al...ts and finishes from manufacturing or,packaging, a...
...onal Union files anti-SLAPP motion against,the Cal... vacate TRO,publicity stunt, OAKLAND, Calif., Apr...SEIU) today filed an anti-Strategic Lawsuit,to Pre...ivisive tactics. The motion cites a temporary rest...
...Jury Endorses Competition in the Durable Medical ...TTLE, April 21 Seattle law firm Williams Kastner,...ay in a business,litigation case involving claims ...man, Warren and Ruth Ann Hall and Halls,Drug Cente...
Other Medicine News:Health News:Medco, UnitedHealth Group Announce Pharmacy Services Agreement 2Health News:New: Longevinex(R) First to Introduce Micronized Resveratrol Matrix - Now Stabilized by Microencapsulation 2Health News:More Americans are Sleeping Thanks to Science 2Health News:SEIU Seeks Damages for CNA's Effort to Silence Workers, Suppress Criticism of Anti-Union Tactics 2Health News:SEIU Seeks Damages for CNA's Effort to Silence Workers, Suppress Criticism of Anti-Union Tactics 3Health News:SEIU Seeks Damages for CNA's Effort to Silence Workers, Suppress Criticism of Anti-Union Tactics 4
(Date:11/27/2009)..., BLOOMINGTON, Minn, Nov. 27 ACUO...cal image management software, data migration tool...ited States Patent and Trademark Office has approv...n Format within a Computer Network." Acuo Technolo...folio of intellectual property. In general, the gr...
(Date:11/25/2009)... , CANOGA PARK, Calif., Nov. 25 ...place rankings in the American Academy of Family P... 2009 EHR User Satisfaction Survey for improving m...nagement, all critical for new ARRA Stimulus legis...ting their EMR had a positive effect in determinin...
(Date:11/25/2009)... , BEDFORD, Mass., Nov. 25 /PRNewswire-FirstCa...daq: HOLX ), a leading developer, manufacturer an... systems and surgical products dedicated to servin...al meeting of the Radiological Society of North Am...er 29 through December 3, 2009 to highlight our ne...
Breaking Medicine Technology:Acuo Technologies Announces Patent for Asset Communication Format Within a Computer Network 2Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 3New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 4Lupus Research Institute announces 2009 novel research grants 10894 1Lupus Research Institute announces 2009 novel research grants 10894 2Lupus Research Institute announces 2009 novel research grants 10894 3Springer and the American College of Medical Toxicology to work together 10889 1Springer and the American College of Medical Toxicology to work together 10889 2Cholesterol Plays Role in Heart Failure Risk 62037 1Cholesterol Plays Role in Heart Failure Risk 62037 2
... VIENNA, Austria, June 11 /PRNewswire-FirstCall/,-...ed the publication of data,from the company,s posi...ea,vaccine in The Lancet. The study, which analyze...eived the Iomai patch-based vaccine were,statistic...ically,significant diarrhea than their counterpart...
...ter Presentation at the Associated Professional Sl...ing, BALTIMORE, June 11 Data was presented today...essional Sleep Societies (APSS),demonstrating that...), an,investigational low-dose, sublingual formula...y that was significantly greater than that produce...
Other Medicine Technology:Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers' Diarrhea Vaccine 2Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers' Diarrhea Vaccine 3Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers' Diarrhea Vaccine 4Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers' Diarrhea Vaccine 5Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers' Diarrhea Vaccine 6Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers' Diarrhea Vaccine 7Intermezzo(R) 3.5 mg Achieves Greater Early Bioavailability Than Ambien(R) 10 mg Despite 65% Lower Dose 2Intermezzo(R) 3.5 mg Achieves Greater Early Bioavailability Than Ambien(R) 10 mg Despite 65% Lower Dose 3Intermezzo(R) 3.5 mg Achieves Greater Early Bioavailability Than Ambien(R) 10 mg Despite 65% Lower Dose 4Intermezzo(R) 3.5 mg Achieves Greater Early Bioavailability Than Ambien(R) 10 mg Despite 65% Lower Dose 5
...ble, light weight, high power Erbium:YAG laser sys... plastic surgery, general surgery, ENT and ophthal... the smallest, yet among the most powerful, Erbium...eatment for younger patients with mild wrinkles or...
...d to induce interstitial laser coagulation or tiss...en used to induce interstitial laser coagulation, ...rgy to heat the targeted tissue to a temperature r...ow temperatures at which carbonization begins. Whe...
...ghly accurate measurements of intraocular pressure...ic for the diagnosis and treatment of glaucoma. H...-year National Institute of Health (NIH) study pub...ickness (CCT) is an important and necessary biomet...
Gonorrhea Swabs
Medicine Products: